Moyamoya disease 2

Common Name(s)

Moyamoya disease 2

Moyamoya disease is a progressive cerebral angiopathy characterized by bilateral internal carotid artery stenosis and abnormal collateral vessels. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage (summary by {1:Kamada et al., 2011}). For a general phenotypic description and a discussion of genetic heterogeneity of moyamoya disease, see MYMY1 ({252350}).
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Moyamoya disease 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Moyamoya disease 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Moyamoya disease 2" returned 6 free, full-text research articles on human participants. First 3 results:

Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.
 

Author(s): Kinga G Blecharz, Dietmar Frey, Tobias Schenkel, Vincent Prinz, Gloria Bedini, Susanne M Krug, Marcus Czabanka, Josephin Wagner, Michael Fromm, Anna Bersano, Peter Vajkoczy

Journal: J. Cereb. Blood Flow Metab.. 2017 Apr;37(4):1527-1539.

 

Moyamoya disease is a rare steno-occlusive cerebrovascular disorder often resulting in hemorrhagic and ischemic strokes. Although sharing the same ischemic stimulus with atherosclerotic cerebrovascular disease, Moyamoya disease is characterized by a highly instable cerebrovascular ...

Last Updated: 31 Dec 1969

Go To URL
Deregulation of Retinaldehyde Dehydrogenase 2 Leads to Defective Angiogenic Function of Endothelial Colony-Forming Cells in Pediatric Moyamoya Disease.
 

Author(s): Ji Yeoun Lee, Youn Joo Moon, Hae-Ock Lee, Ae-Kyung Park, Seung-Ah Choi, Kyu-Chang Wang, Jung Woo Han, Je-Gun Joung, Hyun Seung Kang, Jeong Eun Kim, Ji Hoon Phi, Woong-Yang Park, Seung-Ki Kim

Journal: Arterioscler. Thromb. Vasc. Biol.. 2015 Jul;35(7):1670-7.

 

Moyamoya disease (MMD) is a common cause of childhood stroke, in which the abnormal function of the endothelial colony-forming cell (ECFC) plays a key role in the pathogenesis of the disease. This study was designed to identify genes involved in MMD pathogenesis using gene expression ...

Last Updated: 31 Dec 1969

Go To URL
The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease.
 

Author(s): Young Seok Park, Young Joo Jeon, Hyun Seok Kim, In Bo Han, Seung-Hun Oh, Dong-Seok Kim, Nam Keun Kim

Journal:

 

To investigate the association of single-nucleotide polymorphisms (SNPs) in matrix metalloproteinases (MMPs)-2, -3, and -9 and tissue inhibitor of metalloproteinase (TIMP)-2 with moyamoya disease (MMD). We conducted a case-control study of MMD patients by assessing the prevalence ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Moyamoya disease 2" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.